Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
D

Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Doses

By Insights from 2023 ASH Annual Meeting FEATURING Daniel Wolff
By Insights from 2023 ASH Annual Meeting FEATURING Daniel Wolff
94 views
December 29, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
Videos
10:54

Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Dos…

Insights from 2023 ASH Annual Meeting

D. Wolff

94 views
14:54

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has…

Insights from 2023 ASH Annual Meeting

J. Schetelig

52 views
08:49

ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophylaxis…

Insights from 2023 ASH Annual Meeting

S. Holtan

22 views